Argentina Kidney Function Test Market By Type (Urine Test, Blood Test), By Component (Dipsticks, Reagents, Kits & Assays, and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Region, Competition, Forecast and Opportunities, 2028F

According to National Kidney Foundation of Argentina, kidney disease is a significant health issue in Argentina, with an estimated 10% of the population affected by chronic kidney disease (CKD).

The Government of Argentina has increased its healthcare expenditure in recent years, which has resulted in improved access to healthcare services, including kidney function tests. Also, advancements in technology have resulted in more accurate and efficient diagnostic tests, which, in turn, may drive the growth of the Argentina kidney function test kit market during the forecast period.

Rising Developments in Diagnostic Testing Methods

Biomarker tests, which measure blood and urine levels of specific proteins, including NGAL and Kim-1, are promising in clinical trials as biomarkers for renal disease.

A basic blood test to measure creatinine and electrolyte levels may cost around USD1.77 to USD 3.54, while a more comprehensive panel of tests, including imaging tests and biomarker tests, can cost several USD.

Increasing Prevalence of Diabetes and Hypertension

According to the International Diabetes Federation, an estimated 5.4 million people in Argentina had diabetes in 2019, which represents a prevalence of 10.4% of the population. In addition, according to the World Health Organization, hypertension affects about 33% of adults in Argentina, which represents more than 12 million people.

According to a study published in the journal PLOS ONE in 2019, about 49% of people with diabetes in Argentina were undiagnosed.

The increasing prevalence of diabetes and hypertension in Argentina is driving the demand for kidney function testing in several ways. Routine kidney function testing is recommended for people with diabetes and hypertension to detect any signs of kidney damage at an early stage. As the population ages, the prevalence of diabetes and hypertension increases, leading to a higher demand for kidney function testing among older adults. Such factors will drive the growth of the Argentina kidney function test market during the forecast period.

Increasing Number of Private Hospitals And Clinics

According to the World Health Organization (WHO), Argentina had a total of 8,165 health facilities, including hospitals and clinics, in 2018. The private sector accounted for 52.5% of all health facilities in the country, while the public sector accounted for 47.5% As the number of private hospitals increases becomes more accessible to people for kidney function test due to which it anticipates the growth of Argentina Kidney Function Test Market

According to a report by the Organization for Economic Co-operation and Development (OECD) published in 2019,

Download Free Sample Report

Recent Developments

In November 2020, DiaSys Diagnostic Systems GmbH, a global leader in clinical diagnostics, announced that it had signed a distribution agreement with RAL Group, a prominent distributor of medical equipment in Argentina, to expand its presence in the country's kidney function test market.

In February 2021, Werfen, a leading global healthcare company, completed the acquisition of Accriva Diagnostics, a provider of point-of-care testing solutions, including tests for kidney function, among others.

In September 2021, Siemens Healthineers, a global medical technology company, announced that it had completed the acquisition of Varian Medical Systems' medical imaging business, including its magnetic resonance imaging (MRI) technology, which has the potential to improve the accuracy of kidney function testing.

Market Segmentation

The Argentina kidney function test market can be segmented by type, component, end user, and region. Based on type, the market can be segmented into urine test and blood test. Based on component, the market can be segmented into dipsticks, reagents, kits & assays, and others. Based on end user, the market can be grouped into hospitals & clinics, diagnostics laboratories, and others.

Market Players

Abbott Laboratories Argentina S.A., Roche Diagnostics Argentina S.A., Siemens Healthcare Diagnostics S.A., Beckman Coulter Argentina S.A., Bio-Rad Laboratories S.A., Sysmex Argentina S.A., Mindray Argentina S.A., Horiba Medical Argentina S.A., F. Hoffmann-La Roche Ltd., and Danaher Corporation/Argentina are some of the leading players operating in the Argentina kidney function test market.